| Product Code: ETC8883974 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Portugal`s import shipments of etoricoxib intermediate in 2024 saw significant contributions from China, Switzerland, Belgium, Italy, and India. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a moderate level. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 0.74%, indicating steady growth in the market. Moreover, the growth rate from 2023 to 2024 was notable at 6.56%, suggesting a positive trend in the import of etoricoxib intermediate into Portugal.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Etoricoxib Intermediate Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Etoricoxib Intermediate Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Etoricoxib Intermediate Market - Industry Life Cycle |
3.4 Portugal Etoricoxib Intermediate Market - Porter's Five Forces |
3.5 Portugal Etoricoxib Intermediate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Etoricoxib Intermediate Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Portugal Etoricoxib Intermediate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring pain management, leading to higher demand for etoricoxib intermediate in Portugal. |
4.2.2 Growing focus on research and development in the pharmaceutical industry, driving innovations and new product developments in the etoricoxib intermediate market. |
4.2.3 Favorable government regulations supporting the pharmaceutical sector and encouraging investments in the production of etoricoxib intermediate. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval and market entry, leading to a longer time-to-market for etoricoxib intermediate. |
4.3.2 Price volatility of raw materials impacting the production cost of etoricoxib intermediate in Portugal. |
5 Portugal Etoricoxib Intermediate Market Trends |
6 Portugal Etoricoxib Intermediate Market, By Types |
6.1 Portugal Etoricoxib Intermediate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Portugal Etoricoxib Intermediate Market Revenues & Volume, By In-House Manufacturing, 2021- 2031F |
6.1.4 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
6.2 Portugal Etoricoxib Intermediate Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.3 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2.4 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Acute Pain, 2021- 2031F |
6.2.5 Portugal Etoricoxib Intermediate Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Etoricoxib Intermediate Market Import-Export Trade Statistics |
7.1 Portugal Etoricoxib Intermediate Market Export to Major Countries |
7.2 Portugal Etoricoxib Intermediate Market Imports from Major Countries |
8 Portugal Etoricoxib Intermediate Market Key Performance Indicators |
8.1 Research and development expenditure in the pharmaceutical sector in Portugal. |
8.2 Number of patent filings or approvals for etoricoxib intermediate-related innovations. |
8.3 Adoption rate of etoricoxib intermediate by pharmaceutical companies in Portugal. |
9 Portugal Etoricoxib Intermediate Market - Opportunity Assessment |
9.1 Portugal Etoricoxib Intermediate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Etoricoxib Intermediate Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Portugal Etoricoxib Intermediate Market - Competitive Landscape |
10.1 Portugal Etoricoxib Intermediate Market Revenue Share, By Companies, 2024 |
10.2 Portugal Etoricoxib Intermediate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here